Illumina Inc. Revised Revenue Guidance for the Second Quarter of 2009.
Illumina Inc. revised revenue guidance for the second quarter of 2009. The company said because of a decline in genetic testing equipment business that it now expects revenue for the second quarter to come in at $161 million, compared with its previous forecast of $168 million to $173 million.
